DIRECTOR DEALINGS: Hutchmed CFO banks £4 million; Haleon chair buys

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and Wednesday and not separately reported by Alliance News:

----------

Hutchmed (China) Ltd - Hong Kong-based treatments of cancer and immunological diseases - Chief Financial Officer Johnny Cheng sells 1.3 million shares at average HK$27.07, worth HK$35.2 million, about £3.8 million, on Friday and Monday in Hong Kong. The sale represented about half of his total holding. Hutchmed reported 2022 results on Tuesday last week.

----------

Man Group PLC - London-based hedge fund manager - President Robyn Grew sells 156,717 shares at 287.77 pence, worth £450,992, on Tuesday.

----------

RIT Capital Partners PLC - invests across various asset classes, industries and currencies - Director Philippe Costeletos buys 20,860 shares via Nisaki Family Trust at 2,005p, worth £418,243, on Tuesday. RIT Capital Partners reported 2022 results last week.

----------

Haleon PLC - Weybridge, Surrey-based consumer healthcare products - Chair Dave Lewis buys 31,476 shares at £3.18, worth £99,999, on Friday last week. Non-Executive Director Marie-Anne Aymerich?buys 19,550 shares, also at £3.18 and also on Friday. Haleon reported annual results on Thursday last week.

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.